US Broker Ratings

Humacyte, Inc. (HUMA) Stock Analysis: Potential 461.90% Upside in Biotechnology Sector

In the dynamic landscape of biotechnology, Humacyte, Inc. (NASDAQ: HUMA) emerges as a compelling player, drawing investor attention with a potential upside of 461.90%. Specializing in..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating a 47% Potential Upside in the Healthcare Sector

Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands at a pivotal juncture for investors seeking opportunities in the healthcare sector. With a market capitalization of $414.77 million,..

Abivax SA (ABVX) Stock Analysis: Unraveling the 12.84% Potential Upside in the Biotech Arena

Abivax SA (ABVX), a significant player in the biotechnology sector, is drawing considerable attention from investors due to its promising pipeline and the remarkable potential upside..

AnaptysBio, Inc. (ANAB) Stock Analysis: Exploring a Potential 96% Upside in the Biotech Sector

AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company headquartered in San Diego, is capturing attention in the healthcare sector with its promising pipeline of immunology therapeutics...

Sage Therapeutics, Inc. (SAGE)

⚠️ No article content returned.

..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: A Biotechnology Powerhouse with 186% Revenue Growth

Stoke Therapeutics, Inc. (NASDAQ: STOK) is capturing the attention of investors in the biotechnology sector with its impressive 186% revenue growth, signaling a potential breakthrough in..

Verve Therapeutics, Inc. (VERV) Stock Analysis: Biotech Innovator with a 17.92% Upside Potential

Verve Therapeutics, Inc. (NASDAQ: VERV) is capturing the attention of investors with its pioneering approach in the biotechnology industry, specifically focusing on gene editing to combat..

iRadimed Corporation (IRMD) Investor Outlook: Navigating Growth with a Robust 23.75% ROE

iRadimed Corporation (NASDAQ: IRMD) stands out in the healthcare sector with its focused dedication to developing MRI-compatible medical devices. As the company continues to innovate and..

Tilray Brands, Inc. (TLRY) Stock Analysis: Navigating a Challenging Market with Strategic Diversification

Tilray Brands, Inc. (NASDAQ: TLRY) presents a compelling case study in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market..

Orthofix Medical Inc. (OFIX) Investor Outlook: A 50% Upside Potential with Strong Buy Ratings

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector specializing in medical devices, is capturing investor attention with its promising upside potential and..

STAAR Surgical (STAA) Stock Analysis: Navigating a Challenging Landscape with Eye-Catching Opportunities

STAAR Surgical Company (NASDAQ: STAA), a prominent player in the healthcare sector, focuses on designing and manufacturing implantable lenses and laser-based vision correction solutions. This California-headquartered..

PureTech Health plc (PRTC) Stock Analysis: Unveiling a Potential 182% Upside for Patient Investors

PureTech Health plc (NASDAQ: PRTC) is capturing the attention of investors with its compelling prospects in the biotechnology sector. With a market capitalization of $394.19 million,..

MBX Biosciences, Inc. (MBX) Stock Analysis: Unveiling a Biotech Gem with 279.80% Potential Upside

MBX Biosciences, Inc. (NASDAQ: MBX) is capturing the attention of investors with its ambitious pipeline and extraordinary analyst ratings suggesting a staggering potential upside of nearly..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: Investors Eye 157% Potential Upside with Biotech Innovator

For investors keen on the biotechnology sector, Praxis Precision Medicines, Inc (PRAX) presents an intriguing opportunity. This clinical-stage biopharmaceutical company is focused on developing therapies for..

Emergent BioSolutions Inc. (EBS) Stock Analysis: A Closer Look at a Potential 64% Upside

Emergent BioSolutions Inc. (NYSE: EBS), a key player in the healthcare sector, operates within the specialized niche of drug manufacturing, focusing on preparedness and response solutions..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: 113.82% Potential Upside Sparks Investor Interest

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a dynamic player in the biotechnology sector, is catching the attention of investors with its significant potential upside of 113.82%, according..

Nuvation Bio Inc. (NUVB) Stock Analysis: Unpacking the 123.88% Potential Upside

Nuvation Bio Inc. (NASDAQ: NUVB), a promising player in the biotechnology sector, is drawing significant attention from investors with a striking potential upside of 123.88%. This..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

Castle Biosciences (CSTL) Stock Analysis: A 56.59% Potential Upside in the Healthcare Diagnostics Sector

Castle Biosciences, Inc. (NASDAQ: CSTL) is capturing investor attention with its promising potential upside of 56.59%, as indicated by analyst ratings. Operating within the healthcare sector,..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: A Biotech Gem with a 230% Upside Potential

Relay Therapeutics, Inc. (NASDAQ: RLAY) is making waves in the biotechnology sector, with its innovative approach to drug discovery in targeted oncology and genetic diseases. As..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds